In a new study, researchers sought to identify the heterogeneity of asthma and chronic obstructive pulmonary disease (COPD) overlap syndrome, known as ACOS, in patients with mild to moderate airflow restriction. Using national survey and insurance claims data in Korea, they sought to identify the diverse epidemiological characteristics and subtypes of ACOS associated with exac­erbations, healthcare use, and cost.
Asthma—chronic obstructive pulmonary disease (COPD) overlap syndrome is a disease where features of both conditions are mixed. In a new study, researchers sought to identify the heterogeneity of asthma and COPD overlap syndrome, known as ACOS, in patients with mild to moderate airflow restriction. Using national survey and insurance claims data in Korea, they sought to identify the diverse epidemiological characteristics and subtypes of ACOS associated with exac­erbations, healthcare use, and cost.
Researchers included subjects from the Korean National Health and Nutrition Examination Survey between 2007 and 2012 if they met the criteria of being 40 years or older and having prebronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) of less than 0.7 and FEV1 of at least 50% predicted.
Presence or absence of self-reported wheezing was indicated by W+ or W− and was used as an index of airway hyperresponsiveness. Smoking was indicated by S+ (smokers) or S− (never smoked). The subjects were divided into the following 4 groups: W−/S−; W−/S+; W+/S−; and W+/S+.
Of the 2269 subjects, 410 (18%) with W+ were classified with ACOS. Among those 410 subjects, 154 never-smokers were classified as W+/S− (asthma-predominant ACOS) and 256 smokers were classified as W+/S+ (COPD-predominant ACOS).
Of those without wheezing (W−), 681 were never smokers (W−/S−) and 1178 were smokers (W−/S+). Although mean age was not different, age distribution was significantly different among the 4 groups (P = .001).
Participants aged 40 to 50 years were more frequent in the W+ groups and those 50 to 70 years were more frequent in the S+ groups.
Men were more prevalent in both S+ groups than in both S− groups and in the COPD-predominant ACOS group than in the asthma-predominant ACOS group (both P <.001).
Body mass index and waist circumference were the highest in the COPD-predominant ACOS group (both P <.001). Household income and education level were the highest in the W−/S− group among the 4 groups (P <.001) and were lower in the asthma-predominant ACOS group than in the COPD-predominant ACOS group (P <.001).
The asthma-predominant ACOS group (W+/S−) showed the lowest levels of socioeconomic status, FEV1, FVC% predicted, and quality of life.
The COPD-predominant ACOS group (W+/S+) showed the highest hospitalization rate and outpatient medical cost, as well as more frequent exacerbations and total and outpatient healthcare utilization.
COPD-predominant ACOS was associated with exacerbations compared with the W−/S− group (adjusted odds ratio, 1.79; 95% CI, 1.12-2.85; P = .015) and W−/S+ group (odds ratio, 2.11; 95% CI, 1.43-3.10; P <.001). It was also associated with increased medical cost.
The researchers said that the results show that it is beneficial to identify subtypes of patients with ACOS and appropriately allocate limited medical resources.
Reference
Kim MH, Rhee CK, Kim KJ, et al. Heterogeneity of asthma and COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018:13;1251-1260. doi: 10.2147/COPD.S152916.
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More